Skip to main content
Terug
Watch Compare

United Health Products, Inc.

Datakwaliteit: 100%
UEEC
OTC Manufacturing Measuring & Analyzing Instruments
€ 0,05
▼ € 0,00 (-4,08%)
Marktkapitalisatie: 12,68 M
Prijs
€ 0,05
Marktkapitalisatie
12,68 M
Dagbereik
—
52-Weeksbereik
—
Volume
—
Openen —
50D / 200D Gem.
—
50D / 200D Gem.
—

Quick Summary

Belangrijkste Punten

Negative free cash flow of -815.253,0

Groei

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Kwaliteit

Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A

Veiligheid

Debt / Equity
N/A
Current Ratio0,02
Interest Coverage-32,29

Waardering

PE (TTM)
-3,31
Onder sectorgemiddelde (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (1366 peers)
Metriek Aandeel Sector Mediaan
P/E -3,3 -1,5
P/B — 1,6
ROE % — -53,5
Net Margin % — -41,5
Rev Growth 5Y % — 1,8
D/E — 0,3

Koersdoel Analisten

Geen analistendekking beschikbaar

Winstschattingen

Geen toekomstige schattingen beschikbaar

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0,0 Net Income (TTM) -3,83 M
ROE N/A ROA -4356,54%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -815.253,0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,02
Interest Coverage -32,29 Asset Turnover 0,00
Working Capital -1,96 M Tangible Book Value -3,36 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -3,31 Forward P/E N/A
P/B Ratio N/A P/S Ratio N/A
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -6,43%
Market Cap 12,68 M Enterprise Value 13,60 M
Per Share
EPS (Diluted TTM) -0,02 Revenue / Share 0,00
FCF / Share 0,00 OCF / Share 0,00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 21,28%
SBC-Adj. FCF -815.253 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 0,0 0,0 37.500,0 59,0 643,0
Net Income -2,00 M -2,62 M -1,69 M -30,55 M -15,71 M
EPS (Diluted) -0,01 — — — —
Gross Profit — 0,0 18.856,0 34,0 448,0
Operating Income -2,01 M -2,43 M -2,80 M -29,80 M -14,85 M
EBITDA — — — — —
R&D Expenses 355.936,0 598.810,0 624.564,0 237.458,0 245.218,0
SG&A Expenses 1,65 M 1,83 M 2,20 M 29,56 M 14,60 M
D&A 4.050,0 4.050,0 — — —
Interest Expense 32.322,0 40.512,0 17.022,0 226.139,0 210.025,0
Income Tax 0,0 0,0 0,0 0,0 0,0

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 269.979,0 284.643,0 350.528,0 26.799,0 217.100,0
Total Liabilities 2,71 M 2,00 M 2,42 M 1,17 M 1,17 M
Shareholders' Equity -2,44 M -1,71 M -2,06 M -1,14 M -953.262,0
Total Debt — — — — —
Cash & Equivalents — — 13.377,0 21.799,0 46.076,0
Current Assets 191.683,0 151.822,0 71.039,0 26.799,0 115.750,0
Current Liabilities 1,64 M 1,95 M 2,42 M 1,17 M 1,17 M